BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 15091230)

  • 1. Supporting cells as a target of cisplatin-induced inner ear damage: therapeutic implications.
    Ramírez-Camacho R; García-Berrocal JR; Buján J; Martín-Marero A; Trinidad A
    Laryngoscope; 2004 Mar; 114(3):533-7. PubMed ID: 15091230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats.
    Huang X; Whitworth CA; Rybak LP
    Otol Neurotol; 2007 Sep; 28(6):828-33. PubMed ID: 17450108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin E reduces cisplatin ototoxicity.
    Kalkanis JG; Whitworth C; Rybak LP
    Laryngoscope; 2004 Mar; 114(3):538-42. PubMed ID: 15091231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-n-acetyl-cysteine protection against cisplatin-induced auditory neuronal and hair cell toxicity.
    Feghali JG; Liu W; Van De Water TR
    Laryngoscope; 2001 Jul; 111(7):1147-55. PubMed ID: 11568534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cochlear structure and function after round window application of ototoxins.
    Bauer CA; Brozoski TJ
    Hear Res; 2005 Mar; 201(1-2):121-31. PubMed ID: 15721567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blebs in inner and outer hair cells: a pathophysiological hypothesis.
    Ramírez-Camacho R; García-Berrocal JR; Trinidad A; Verdaguer JM; Nevado J
    J Laryngol Otol; 2008 Nov; 122(11):1151-5. PubMed ID: 18184450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of organotypic cultures of Corti's organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hair cells.
    Kopke RD; Liu W; Gabaizadeh R; Jacono A; Feghali J; Spray D; Garcia P; Steinman H; Malgrange B; Ruben RJ; Rybak L; Van de Water TR
    Am J Otol; 1997 Sep; 18(5):559-71. PubMed ID: 9303151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity.
    Cooper LB; Chan DK; Roediger FC; Shaffer BR; Fraser JF; Musatov S; Selesnick SH; Kaplitt MG
    Otol Neurotol; 2006 Jun; 27(4):484-90. PubMed ID: 16791039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of intratympanic lactate injection in the prevention of cisplatin-induced ototoxicity.
    Nader ME; Théorêt Y; Saliba I
    Laryngoscope; 2010 Jun; 120(6):1208-13. PubMed ID: 20513041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin-induced hearing loss does not correlate with intracellular platinum concentration.
    Ramírez-Camacho R; Fernández DE; Verdaguer JM; Gómez MM; Trinidad A; García-Berrocal JR; Corvillo MA
    Acta Otolaryngol; 2008 May; 128(5):505-9. PubMed ID: 18421602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral ethanol potentiates the loss of outer hair cells in cisplatin-exposed rats.
    Madnani D; Li G; Frenz CM; Frenz DA
    Otolaryngol Head Neck Surg; 2007 Aug; 137(2):327-31. PubMed ID: 17666265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caspase inhibitors, but not c-Jun NH2-terminal kinase inhibitor treatment, prevent cisplatin-induced hearing loss.
    Wang J; Ladrech S; Pujol R; Brabet P; Van De Water TR; Puel JL
    Cancer Res; 2004 Dec; 64(24):9217-24. PubMed ID: 15604295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Light microscopy study of cisplatin-induced ototoxicity in rats.
    de Freitas MR; de Castro Brito GA; de Carvalho JV; Gomes RM; Barreto Martins MJ; de Albuquerque Ribeiro R
    J Laryngol Otol; 2009 Jun; 123(6):590-7. PubMed ID: 19144244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of different approaches for establishing cisplatin-induced cochlear lesions in mice.
    He J; Yin S; Wang J; Ding D; Jiang H
    Acta Otolaryngol; 2009 Dec; 129(12):1359-67. PubMed ID: 19922082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a single high dose of cisplatin on the melanocytes of the stria vascularis in the guinea pig.
    Laurell G; Ekborn A; Viberg A; Canlon B
    Audiol Neurootol; 2007; 12(3):170-8. PubMed ID: 17259704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Histocochleographic studies of the late toxicity of cisplatin].
    Löw M; Federspil P
    HNO; 1992 Jul; 40(7):271-6. PubMed ID: 1500305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of antioxidants in protection from ototoxic drugs.
    Sergi B; Fetoni AR; Ferraresi A; Troiani D; Azzena GB; Paludetti G; Maurizi M
    Acta Otolaryngol Suppl; 2004 May; (552):42-5. PubMed ID: 15219046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen.
    Lynch ED; Gu R; Pierce C; Kil J
    Hear Res; 2005 Mar; 201(1-2):81-9. PubMed ID: 15721563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Src-protein tyrosine kinase inhibitor to reduce cisplatin ototoxicity while preserving its antitumor effect.
    Bielefeld EC; Tanaka C; Chen GD; Coling D; Li M; Henderson D; Fetoni AR
    Anticancer Drugs; 2013 Jan; 24(1):43-51. PubMed ID: 22828384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin ototoxicity to the rat inner ear: a role for HMG1 and iNOS.
    Li G; Liu W; Frenz D
    Neurotoxicology; 2006 Jan; 27(1):22-30. PubMed ID: 16125245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.